1. Bateman A, Bullough F, Murphy S, Emiliusen L, Lavillette D, Cosset FL et al. Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. Cancer Res 2000; 60: 1492–1497.
2. Diaz RM, Bateman A, Emiliusen L, Fielding A, Trono D, Russell SJ et al. A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy. Gene Therapy 2000; 7: 1656–1663.
3. Bateman AR, Harrington KJ, Kottke T, Ahmed A, Melcher AA, Gough MJ et al. Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells. Cancer Res 2002; 62: 6566–6578.
4. Higuchi H, Bronk SF, Bateman A, Harrington K, Vile RG, Gores GJ . Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy. Cancer Res 2000; 60: 6396–6402.
5. Srivastava P . Roles of heat–shock proteins in innate and adaptive immunity. Nat Rev Immunol 2002; 2: 185–194.